Which of the following is used in the management of prolcatinoma: September 2011: (A) Reserpine, (B) Methyldopa, (C) Bromocriptine, (D) Metoclopramide
Answer is C. Ans. C: Bromocriptine Dopamine agonists are the first line therapy for majority of the patients of prolcatinoma. Ergot derived dopamine agonists are preferred